Skip to search formSkip to main contentSkip to account menu

dehydroretronecine

Known as: 6,7-dihydro-7-hydroxy-1-hydroxymethyl-5H-pyrrolizine, dehydro-retronecine, dehydroretro-necine 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
1982
Highly Cited
1982
Dehydroretronecine, an antimitotic and carcinogenic agent, reacted with deoxyguanosine at pH 7.4 in vitro to yield in nearly… 
Highly Cited
1978
Highly Cited
1978
Monocrotaline was placed in the drinking water of rats at a concentration of 20 mg per liter for periods of up to three weeks… 
Highly Cited
1977
Highly Cited
1977
The covalent interaction of dehydroretronecine, a carcinogenic metabolite of the pyrrolizidine alkaloid monocrotaline, with… 
Highly Cited
1975
Highly Cited
1975
Two groups of rat were given s.c. injections of either monocrotaline or its major detectable metabolite, dehydroretronecine…